Current Obstetrics and Gynecology Reports

, Volume 2, Issue 4, pp 232–239 | Cite as

Twin and Preterm Labor: Prediction and Treatment

High-risk Gestation and Prenatal Medicine (T-F Chan, Section Editor)


Twin pregnancies are increasing. Preterm birth is a major health problem with high incidence all over the world. It is known to have a higher incidence in twin pregnancies as well as being higher in IVF/ICSI pregnancies. Prediction of preterm birth in twins through transvaginal cervical length measurement and vaginal fetal fibronectin measurement are good and well-documented methods. However, this could not be applied to IVF pregnancies. Prevention of preterm birth by administration of vaginal natural progesterone or IM synthetic progesterone injections is not effective in twins. The situation was similar with administration of progesterone to IVF twin pregnancies. Prophylactic cerclage for prevention of preterm birth in twins resulted in an increase of the incidence of preterm birth. Tocolytics also are ineffective, although nifedipine may have a role in treatment of threatened preterm birth in twins.


Preterm birth Twins In vitro fertilization Transvaginal ultrasound Cervical length Vaginal progesterone Prophylactic cerclage Twins High-risk gestation Preterm labor 


Twins constitute 2-4 % of all births, and the rate of twining has increased by 76 % between 1980 and 2009. The rate of preterm birth <37 weeks among twins is approximately 60 % [1]. Two chief reasons have been attributed to this increase in multiple births: women’s choice to postpone their (first) pregnancy, which has resulted in advanced maternal age, and the liberal use of assisted reproductive techniques [2].

Twin pregnancies, compared with singletons, are at increased risk for fetal anomalies, preterm births, aberrant fetal growth, cerebral palsy, and perinatal and infant mortality. Maternal complications associated with twin pregnancies include hypertensive disorders, gestational diabetes, cesarean delivery, postpartum hemorrhage, and maternal mortality [1].

Incidence of Preterm Labor

Fifteen million preterm births occur every year and this number is rising. One million babies die from preterm birth complications annually. Five to eighteen percent is the range of preterm birth rates across 184 countries of the world; >80 % of preterm births occur between 32-37 weeks of gestation, and most of these babies can survive with essential newborn care. (3)

According to the WHO report published 2009, the overall preterm birth rate was 9.6 %. The highest rates of prematurity occurred in Africa, 11.9 %, and North America, 10.6 %. Europe had the lowest rate of 6.2 % [3].

The percentage of singletons born less than 37 weeks of gestation was 11.1 % compared with 61.9 % for multiples. The rate of preterm birth less than 32 weeks of gestation was much more common among multiples than among singletons: 13.3 % versus 1.6 % [4].

Short-term morbidities associated with early preterm delivery include respiratory distress syndrome, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, bronchopulmonary dysplasia, sepsis, patent ductus arteriosus, and retinopathy of prematurity. Long-term morbidities include cerebral palsy, cognitive defects, and social and behavioral problems [5], in addition to the economic burden on the family and the country.

Etiology of Preterm Birth

The causes for preterm birth in twins are classified into three clinical subtypes: preterm birth after (preterm) premature rupture of membranes (PROM), spontaneous onset of labor (these two groups are termed spontaneous preterm birth), and medically indicated preterm birth after iatrogenic obstetrical interventions for maternal-fetal indications [6, 7].

Twin pregnancies are more liable to maternal hypertension, fetal distress, fetal growth restriction, and placental abruption, leading to the need for early termination of the pregnancy [8]. The incidence of preterm birth is reported higher for IVF/ICSI pregnancies [9, 10]. One of the etiological factors that could possibly affect the incidence of preterm birth in IVF twin pregnancies includes obesity. Body mass index (BMI) > 35 kg/m2 in twins was associated with a threefold increased risk of very early preterm birth (6.1 % vs. 2 %) and a twofold increased risk of very preterm birth (11.5 % vs. 5.9 %) compared with women of normal weight (BMI 18.4-24.9 kg/m2) [11].

Mechanisms of Preterm Birth

The mechanisms for preterm birth are still unclear. It could be associated either with a premature activation of the physiological contracting process or with a pathological factor responsible for uterine contractions, leading to preterm delivery [12, 13].

In twins, etiological factors for preterm birth include uterine overdistention [14]. Myometrial distention increases myometrial contractility, releases prostaglandins, and upregulates oxytocin receptors, all of which are implicated in the cascade of events that occur in early labor [13]. Factors, such as stretch, placental corticotrophin-releasing hormone, and lung maturity factors, are stronger in multiple pregnancies due to the increased fetal and placental mass [15]. The risk of preterm birth is higher in monochorionic diamniotic twins, which could be explained by the occurrence of twin-to-twin transfusion syndrome (TTTS) in 15 % of this type of twins [16]. Nulliparous women with twin gestations are at significantly higher risk for preterm delivery compared with multiparous women [17]. Fetal sex appears to be a risk factor for preterm delivery in spontaneously conceived dichorionic twin gestations. Twin pregnancies with one or two male fetuses are at higher risk for spontaneous preterm delivery than those with only females [18].

Prediction of Preterm Birth

Cervical length measurement using transvaginal ultrasound is the best method for prediction of preterm birth in twin pregnancies and was demonstrated as sensitive in twins as in singletons [19]. A large number of prospective studies [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30] have shown the predictive value of midtrimester cervical length measurement in twin pregnancies; these data were collected in two large meta-analyses. The first meta-analysis included 21 studies, 16 in asymptomatic women and only 5 in symptomatic women; the collected data included 3,523 women. The most accurate prediction for preterm birth <32 weeks and <34 weeks was made in asymptomatic women with a cervical length ≤20 mm at 20-24 weeks gestation. Cervical length ≤25 mm at 20-24 weeks gestation had a pooled positive likelihood ratio of 9.6 to predict preterm birth <28 weeks gestation. The predictive accuracy of cervical length for preterm birth was low in symptomatic women [31•]. The second meta-analysis using the ROC curve to obtain an optimum cutoff for cervical length indicated a good predictive capacity of short cervical length for preterm birth [32•].

Two retrospective studies did not show a predictive value of cervical length measurement but still concluded that the importance of cervical length measurement lies in its strong negative predictive value [33, 34]. Changes of cervical length over time also is a predictor for preterm birth, a cervical length that decreases by 20 % over two measurements is a significant predictor of very preterm birth, even in the setting of a normal cervical length [35]. Serial cervical length measurements in twin pregnancies, is recommended starting <24 weeks [35].

Timing of Cervical Length Measurement

Most published studies agreed on measurement at the midtrimester between 16-24 weeks [36]. A more recent study recommended transvaginal ultrasound for assessment of cervical length between 22-24 weeks for prediction of spontaneous preterm birth in twin pregnancy [37]. However, one study reported cervical measurement from as early as 13 to 34 weeks and concluded that the risk of preterm delivery is increased when shorter cervical length is detected at an earlier gestational age [38]. Similarly, the finding of two cervical length measurements at 20-23 weeks gestation and 3-5 weeks later with a difference of 25 % between each measurement is a good predictor of preterm birth in asymptomatic twins even when cervical length is >25 mm [39].


Cervical funneling seen at midtrimester had a high sensitivity and specificity for prediction of the preterm birth, which was higher for gestations born <32 weeks than <35 weeks (86 % and 54 %, and specificity 78 % and 82 %, respectively) [40]. Funneling is seen by transvaginal ultrasound. The patient should be examined in the dorsal lithotomy position with an empty bladder without undue pressure on the cervix, and the examiner should wait for up to 5 minutes to note any changes in cervical length and shape. Funneling is defined as dilatation of the internal os >5 mm in width for a period of at least 3 minutes [40].

The incidence of funneling differs according to position of patient. It was greater in an upright compared with a recumbent maternal position by 12.3 % in singleton and 13.1 % in twin pregnancies before 25 weeks and by 13 % and 21.6 % between 25 and 30 weeks, respectively. Evaluation of the cervix with the woman in the upright position permits earlier detection of funneling. This may enable earlier and more appropriate intervention to avoid spontaneous preterm birth [41].

Situation in IVF Pregnancies

Is there a Role for Midtrimester Cervix Measurement in IVF/ICSI Patients for the Prediction of Preterm Birth?

We performed a prospective, controlled study to compare the midtrimester transvaginal cervical measurement in 222 twins (group A) and 122 singleton ICSI pregnancies (group B) with 51 spontaneous pregnancies (group C). No significant difference in mean cervical length was found between the three groups: group A, 37.6 mm; group B, 37.2 mm, and group C, 39.2 mm, despite a very high incidence of preterm birth (<34 weeks) in the two study groups compared with the spontaneous pregnancy control group: 30.5 % in group A; 17.6 % in group B; and 3.9 % in group C (P = 0.011). Using the ROC curve to establish the optimum cervical length below which the incidence of preterm birth is expected to be high gave a poor sensitivity and specificity. Our results showed that contrary to the situation in spontaneous pregnancies where cervical length measurement is a good predictor for preterm birth cervical length measurement in singleton, as well as twin ICSI pregnancies, is not a good predictor [42].

These results were confirmed by our recent study [43••] in which we studied the effect of progesterone for prevention of preterm birth in ICSI singleton and twin pregnancies. We measured cervical length as well at midtrimester for all participant pregnant females (unpublished data); similar to our previous results the cervical length was not significantly different between those who delivered preterm <37 weeks (mean cervical length 35.5 mm) and those who delivered >37 weeks of gestation (36.3 mm; p = 0.216) [43••].

Cervical Fetal Fibronectin and Transvaginal ultrasound cervical measurement in prediction of preterm birth and threatened preterm labor

A retrospective study combining a positive cervical fetal Fibronectin with cervical length measurement <20 mm showed a significantly higher positive predictive value for delivery at all gestational ages than either positive test alone. In twins with normal cervical length, a positive fetal fibronectin test was a strong predictor of spontaneous preterm birth [29].

The negative predictive value of fetal fibronectin testing in predicting delivery within 14 days of testing was 97 % for twin gestations, comparable to 99 % for singletons [44]. A systematic review and meta-analysis showed that cervicovaginal fetal fibronectin provides moderate to minimal prediction of preterm birth in women with multiple pregnancies, but it was most accurate in predicting spontaneous preterm birth within 7 days of testing in women with twin pregnancies and threatened preterm birth [45].

Prevention of preterm birth in Twins

Cerclage in twins

Is there a Role for Prophylactic Cerclage in Twins?

The situation in twins is clearly contrary to that of singletons. A large prospective study compared prophylactic cerclage in twin pregnancies with no cerclage, in reducing preterm birth <32 weeks and found a significant increase in preterm birth rate among those who underwent cerclage and no difference in gestational age at birth [46]. An older meta-analysis reported a similarly significant increase in incidence of preterm birth <35 weeks in twins with a short cervix who underwent cerclage cervix, previous history of preterm birth , in contrast to singletons that had a significant reduction of preterm birth with cerclage [47].


Has a physiological effect on uterine quiescence mediated by a direct effect on intracellular calcium concentration and prostaglandin synthesis [12].

The positive effect of vaginal progesterone on reducing the rate of preterm birth in singleton pregnancies with short cervix, as well as singleton patients with history of previous preterm birth, has been confirmed by a large number of randomized studies [48, 49, 50, 51, 52, 53, 54, 55•]. However, in twins the situation was found to be different; two large, randomized, controlled studies—the PREDICT study [56••] and the STOPPIT study [57••]—showed no reduction of the preterm birth rate with natural vaginal progesterone administration in twin pregnant patients with short cervices [58]. The effect was similar with 17 hydroxy progesterone weekly IM injections [59, 60, 61, 62].

A recently published, randomized, controlled study showed an increase in the rate of preterm birth <32 weeks in symptomatic twins with short cervix who received IM synthetic progesterone injections [63•]. The ineffectiveness of progesterone was similar even when the dose of progesterone was increased to 400 mg per day [64].

One potential explanation of the negative results of prophylactic cerclage and progesterone on twins is that preterm birth in twin pregnancies is more often because of uterine distention and contraction than due to cervical problems [63•].

Role of Progesterone in Prevention of Preterm Birth in IVF Pregnancies

A randomized, placebo-controlled study was performed by our group. The purpose was to study the effect of daily 400 mg of vaginal progesterone suppositories for prevention of preterm birth in singleton and twin ICSI pregnancies. In the total study group, including 306 patients, 161 received progesterone and 145 placebo and no statistical significant difference in preterm birth rate (<37 weeks) was found between both groups (P = 0.6). Subgroup analysis showed a significant reduction in preterm birth rates in the singleton group that received progesterone. As for the twin pregnancy group, there was no significant difference in preterm birth rate in those who received progesterone versus placebo. The results of our study agreed with the current available literature that progesterone does not prolong twin pregnancies [43••].

Bed Rest

A Cochrane review of randomized trials studying the effect of hospital bed rest in multiple pregnancies found no evidence that this practice should be applied to all multiple pregnancies and should not be recommended for routine clinical practice [65].


One trial under way since 2009 is studying the effect of prophylactic pessary insertion in twin pregnancies with shortened cervix; women will be randomly allocated to receive either a cervical pessary or no intervention. The cervical pessary will be placed in situ at 16 to 20 weeks and kept up to 36 weeks gestation or until delivery. The primary outcome is perinatal death or severe morbidity. Secondary outcome measures are time to delivery, preterm birth rate before 32 and 37 weeks, days of admission in neonatal intensive care unit, maternal morbidity, maternal admission days for preterm birth and costs [66]. Only one small study reported some positive effect of pessary insertion in twins [67].

Management of Threatened Preterm Birth in Twin Pregnancies

Tocolysis and Treatment of Preterm Birth

Mechanism of Action of Tocolysis

Myometrial contractility is a complex process based on myocyte function. It involves the presence of hormonal receptors, ions channels, intercell gap junctions, and regulatory proteins, such as oxytocin, endothelin, tachykinin, and angiotensin [68, 69]. The increase of intracellular calcium concentration is essential for the uterine smooth muscle contraction [69].

β Adrenergic Receptor Agonists

Selective β2 agonists, such as ritodrine and salbutamol, impair intracellular cyclic AMP concentration and facilitate myometrial relaxation [69, 70]. A Cochrane review including 11 randomized, controlled trials, involving 1,332 women reported that these agents were more efficient than placebo for delaying preterm birth for 2 days [70, 71].

In twins, there is no evidence that selective β2 agonists prevent preterm birth. A Cochrane review on the use of oral betamimetics for reducing preterm birth in twins showed insufficient evidence to support or refute the use of prophylactic oral betamimetics [72].

Magnesium Sulphate

There is evidence and recommendation to administer magnesium sulphate in expected preterm births, especially very preterm births <30 weeks, for neuroprotection and reduction of incidence of cerebral palsy [73].

As a tocolytic, magnesium sulphate is a calcium antagonist; it decreases calcium intracellular concentration and inhibits contraction process [69]. It has been classed as one of the three most effective drugs for delay of delivery for 48 weeks [74], and its effectiveness was similar in singletons and twins [75].

Prostaglandin-Synthase Inhibitors

Indomethacin, a nonspecific COX inhibitor, is recommended as a tocolytic; however, use should be restricted in duration and limited to pregnancies below 32 weeks because of fetal ductus arteriosus closure risk and decreased urine production responsible for oligohydramnios [13, 71, 76, 77]. The various types of available tocolytics compared with placebo resulted in the highest delay of delivery by 48 hours with prostaglandin inhibitors (odds ratio 5.39) followed by magnesium sulfate (2.76) calcium channel blockers (2.71), beta mimetics (2.41), and the oxytocin receptor blocker atosiban (2.02) [74]. Prostaglandin inhibitors and calcium channel blockers gave the best results to delay delivery for 48 hours, to reduce respiratory distress syndrome, neonatal mortality, and had the least maternal side effects [74].

Calcium-Channel Blockers

Calcium-channel blockers interfere with the calcium ions transfer through the myometrial cell membrane. They decrease intracellular free calcium concentration and induce myometrial relaxation [13]. A recent systematic review based on 26 trials and 2,179 patients (8 of the studies contained twins) confirmed higher efficiency and lower side-effects incidence in the nifedipine group compared with β adrenergic receptor agonists-treated patients used for acute tocolysis (delay of delivery 48 hours up to 7 days [78]. As for the use of nifedipine for maintenance tocolysis, a recently published, randomized, controlled study comparing the effect of maintenance tocolysis with nifedipine in threatened preterm labor resulted in no significant reduction of perinatal adverse outcome in the study group and the study could not advise the use of nifedipine as maintenance tocolysis [79]. Tocolysis with nifedipine is proven as effective and safe for use in both singleton and twin gestations [80].

In singleton and multiple gestations, the role of tocolysis in the setting of acute preterm labor is to attempt to delay delivery long enough to administer corticosteroids to promote fetal lung maturity [81].


Infection is one of causal factors of preterm labor with an incidence of 20–40 %, especially before 30 weeks [12]. In the presence of preterm birth with intact membranes, the prophylactic administration of antibiotics is not recommended [82]. But if there is a preterm rupture of the membranes (PROM), studies show a significant decrease of preterm delivery and chorioamnionitis rate in the treated group [83]. In bacterial vaginosis associated with pregnancy, antibiotics were found to eradicate infection, but they showed no effect on the incidence of preterm delivery [84].

Therapeutic Emergency Cervical Cerclage in Twins

Some reports have shown the effectiveness of cerclage in dichorionic twins to save the second twin after delivery of the first twin [85]. The largest study published so far [86] to check the effectiveness of emergency cerclage, which comprised a total of 414 sets of twin gestations and 92 sets of triplet gestations, could not show any significant prolongation of pregnancy duration in the ultrasound indicated cerclage (closed cervical length ≤2.5 cm group versus conservative management) [87]. As for triplets, no benefit from cerclage placement was found even when cervical shortening is documented [88].


Preterm birth is a major increasing health problem, especially with twins. Although the prediction of preterm birth is possible in twins by transvaginal ultrasound cervix measurement and possibly measurement of fetal Fibronocten, no effective preventive or treatment measure is available for management of preterm birth in twins. Management should involve decreasing the number of twins resulting from ART procedures, such as single embryo transfer and careful monitoring of ovulation induction. The role of progesterone if started early in pregnancy should be studied.


Compliance with Ethics Guidelines

Conflict of Interest

Mona Aboulghar and Yomna Islam declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Ananth CV, Chauhan SP. Epidemiology of twinning in developed countries. Semin Perinatol. 2012;36:156–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Ananth CV, Joseph KS, Smulian JC. Trends in twin neonatal mortality rates in the United States, 1989 through 1999: influence of birth registration and obstetric intervention. Am J Obstet Gynecol. 2004;190:1313–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Blencowe H, Cousens S, Oestergaard M. National, regional and worldwide estimates of preterm birth rates in the year 2010 with time trends for selected countries since 1990: a systematic analysis. Lancet. 2012;379(9832):2162–72.PubMedCrossRefGoogle Scholar
  4. 4.
    Martin JA, Hamilton BE, Sutton PD, et al. National vital statistics reports. Vol. 57. Hyattsville, MD: National Center for Health Statistics; 2009. Births: final data for 2006.Google Scholar
  5. 5.
    Brehaut JC, Kohen DE, Garner RE, et al. Health among caregivers of children with health problems: findings from a Canadian population-based study. Am J Public Health. 2009;99:1254–62.PubMedCrossRefGoogle Scholar
  6. 6.
    Savitz DA, Blackmore CA, Thorp JM. Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. Am J Obstet Gynecol. 1991;164:467–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Alexander G. In: Behrman R, Stith Butler A, editors. Prematurity at birth: determinants, consequences and geographic variation. In Preterm birth: Causes, consequences, and prevention. Washington, DC: The National Academies Press; 2006. p. 501–35.Google Scholar
  8. 8.
    Gardner MO, Goldenberg RL, Cliver SP, et al. The origin and outcome of preterm twin pregnancies. Obstet Gynecol. 1995;85:553–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Moini A, Shiva M, Arabipoor A. Obstetric and neonatal outcomes of twin pregnancies conceived by assisted reproductive technology compared with twin pregnancies conceived spontaneously: a prospective follow-up study. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):29–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Pinborg A, Loft A, Schmidt L, et al. Maternal risks and perinatal outcome in a Danish national cohort of 1005 twin pregnancies: the role of in vitro fertilization. Acta Obstet Gynecol Scand. 2004;83(1):75–84.PubMedGoogle Scholar
  11. 11.
    Dickey RP, Xiong X, Gee RE. Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril. 2012;97(2):349–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010;362(6):529–35.PubMedCrossRefGoogle Scholar
  13. 13.
    Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG: Int J Obstet Gynaecol. 2006;113 Suppl 3:17–42.CrossRefGoogle Scholar
  14. 14.
    Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol. 2011;38:1–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Stock S, Norman J. Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med. 2010;15(6):336–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Morikawa M, Yamada T, Sato S. Contribution of twin-to-twin transfusion syndrome to preterm birth among monochorionic biamniotic and bichorionic biamniotic twin pregnancies. J Perinat Med. 2011;39(5):557–61.PubMedCrossRefGoogle Scholar
  17. 17.
    Hannoun A, Usta IM, Awwad J. Effect of parity on maternal and neonatal outcomes in twin gestations. Acta Obstet Gynecol Scand. 2012;91(1):117–21.PubMedCrossRefGoogle Scholar
  18. 18.
    Klein K, Worda C, Stammler-Safar M. Does fetal sex influence the risk of preterm delivery in dichorionic twin pregnancies after spontaneous conception? Twin Res Hum Genet. 2010;13(5):495–500.PubMedCrossRefGoogle Scholar
  19. 19.
    To MS, da Fonseca EB, Molina FS, et al. Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins. Am J Obstet Gynecol. 2006;194:1360–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Crane JM, Van den Hof M, Armson BA, et al. Transvaginal ultrasound in the prediction of preterm delivery: singleton and twin gestations. Obstet Gynecol. 1997;90:357–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Imseis HM, Albert TA, Iams JD. Identifying twin gestations at low risk for preterm birth with a transvaginal ultrasonographic cervical measurement at 24 to 26 weeks’ gestation. Am J Obstet Gynecol. 1997;177:1149–55.PubMedCrossRefGoogle Scholar
  22. 22.
    Grisaru-Granovsky S, Farine D, Barrett J, et al. Is a single ultrasound measurement of cervical length a predictor of the risk of preterm delivery in multifetal pregnancy? Am J Obstet Gynecol. 1998;178(1S):191S.Google Scholar
  23. 23.
    Souka AP, Heath V, Flint S, et al. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol. 1999;94:450–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Guzman ER, Walters C, O’Reilly-Green C, et al. Use of cervical ultrasonography in prediction of spontaneous preterm birth in twin gestations. Am J Obstet Gynecol. 2000;183:1103–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Yang JH, Kuhlman K, Daly S, et al. Prediction of preterm birth by second trimester cervical sonography in twin pregnancies. Ultrasound Obstet Gynecol. 2000;15:288–91.PubMedCrossRefGoogle Scholar
  26. 26.
    Vayssiere C, Favre R, Audibert F, et al. Cervical length and funneling at 22 and 27 weeks to predict spontaneous birth before 32 weeks in twin pregnancies: a French prospective multicenter study. Am J Obstet Gynecol. 2002;187:1596–604.PubMedCrossRefGoogle Scholar
  27. 27.
    Gibson JL, Macara LM, Owen P, et al. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol. 2004;23:561–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Sperling L, Kiil C, Larsen LU, et al. How to identify twins at low risk of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2005;26:138–44.PubMedCrossRefGoogle Scholar
  29. 29.
    Klein K, Gregor H, Hirtenlehner-Ferber K, et al. Prediction of spontaneous preterm delivery in twin pregnancies by cervical length at mid-gestation. Twin Res Hum Genet. 2008;11:552–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Fox NS, Saltzman DH, Klauser CK, et al. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol. 2009;201:313.e1. 313.e5.CrossRefGoogle Scholar
  31. 31.
    • Conde-Agudelo A, Romero R, Hassan SS. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and meta-analysis. Am J Obstet Gynecol. 2010;203(128.e):128.e1–12. This is a large systematic review showing the importance of transvaginal ultrasound in prediction of preterm birth.CrossRefGoogle Scholar
  32. 32.
    • Lim AC, Hegeman MA, Huis In 'T Veld MA. Cervical length measurement for the prediction of preterm birth in multiple pregnancies: a systematic review and bivariate meta-analysis. Ultrasound Obstet Gynecol. 2011;38(1):10–7. See comment for 31. PubMedCrossRefGoogle Scholar
  33. 33.
    Sauvanaud C, Equy V, Faure C. Transvaginal sonographic cervical length and prediction of preterm delivery in twin pregnancies with preterm labor. J Gynecol Obstet Biol Reprod (Paris). 2013.Google Scholar
  34. 34.
    Schwartz R, Prieto J. Shortened cervical length as a predictor of preterm delivery in twin gestations. J Reprod Med. 2010;55(3–4):147–50.PubMedGoogle Scholar
  35. 35.
    Fox NS, Rebarber A, Klauser CK. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies using the change in cervical length over time. Am J Obstet Gynecol. 2010;202(2):155.e1–4.CrossRefGoogle Scholar
  36. 36.
    Berghella V. Universal cervical length screening for prediction and prevention of preterm birth. Obstet Gynecol Surv. 2012;67(10):653–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Asnafi N, Basirat Z, Hajian-Tilaki K. Assessment of cervical length by transvaginal ultrasonography to predict preterm delivery in twin pregnancy. J Matern Fetal Neonatal Med. 2013.Google Scholar
  38. 38.
    Ehsanipoor RM, Haydon ML, Lyons Gaffaney C. Gestational age at cervical length measurement and preterm birth in twins. Ultrasound Obstet Gynecol. 2012;40(1):81–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Khalil MI, Alzahrani MH, Ullah A. The use of cervical length and change in cervical length for prediction of spontaneous preterm birth in asymptomatic twin pregnancies. Eur J Obstet Gynecol Reprod Biol. 2013.Google Scholar
  40. 40.
    Vayssière C, Favre R, Audibert F. Cervical length and funneling at 22 and 27 weeks to predict spontaneous birth before 32 weeks in twin pregnancies: a French prospective multicenter study. Am J Obstet Gynecol. 2002;187(6):1596–604.PubMedCrossRefGoogle Scholar
  41. 41.
    Arabin B, Roos C, Kollen B. Comparison of transvaginal sonography in recumbent and standing maternal positions to predict spontaneous preterm birth in singleton and twin pregnancies. Ultrasound Obstet Gynecol. 2006;27(4):377–86.PubMedCrossRefGoogle Scholar
  42. 42.
    Aboulghar MM, Aboulghar MA, Mourad L. Ultrasound cervical measurement and prediction of spontaneous preterm birth in ICSI pregnancies: a prospective controlled study. Reprod Biomed Online. 2009;18(2):296–300.PubMedCrossRefGoogle Scholar
  43. 43.
    •• Aboulghar MM, Aboulghar MA, Amin YA. The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies. Reprod BioMed Online. 2012;25:133–8. This is the only randomized, controlled study on effect of progesterone in exclusively IVF/ICSI pregnancies for prevention of preterm birth. PubMedCrossRefGoogle Scholar
  44. 44.
    Singer E, Pilpel S, Bsat F, et al. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol. 2007;109:1083–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Conde-Agudelo A, Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2010;23(12):1365–76.PubMedCrossRefGoogle Scholar
  46. 46.
    Roman AS, Saltzman DH, Fox N. Prophylactic cerclage in the management of twin pregnancies. Am J Perinatol. 2013.Google Scholar
  47. 47.
    Berghella V, Odibo AO, To MS. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005;106(1):181–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–24.PubMedCrossRefGoogle Scholar
  49. 49.
    Mackenzie R, Walker M, Armson A, et al. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194(5):1234–42.PubMedCrossRefGoogle Scholar
  50. 50.
    DeFranco EA, O’Brien JM, Adair CD, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30:697–705.PubMedCrossRefGoogle Scholar
  51. 51.
    Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Dodd JM, Flenady VJ, Cincotta R, et al. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol. 2008;112(1):127–34.PubMedCrossRefGoogle Scholar
  53. 53.
    Rode L, Langhoff-Roos J, Andersson C, et al. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88(11):1180–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Majhi P, Bagga R, Kalra J, et al. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India. J Obstet Gynaecol. 2009;29:493–8.PubMedCrossRefGoogle Scholar
  55. 55.
    • Hassan SS, Romero R, Vidyadhari D. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18–31. One of the most cited publications on the use of vaginal progesterone for prevention of preterm birth in a large, randomized, multicenter study. PubMedCrossRefGoogle Scholar
  56. 56.
    •• Rode L, Klein K, Nicolaides KH. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol. 2011;38(3):272–80. This and reference 57 are large, randomized, controlled studies that showed that progesterone is not effective in prevention of preterm birth in twins. PubMedCrossRefGoogle Scholar
  57. 57.
    •• Norman JE, Mackenzie F, Owen P. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 373(9680):2034–40. doi:10.1016/S0140-6736(09)60947-8. This and reference 56 are large, randomized, controlled studies that showed that progesterone is not effective in prevention of preterm birth in twins.
  58. 58.
    Wood S, Ross S, Tang S et al. Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. J Perinat Med. 2012.Google Scholar
  59. 59.
    Combs CA, Garite T, Maurel K. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol. 2011;204(3):221.e1–8.CrossRefGoogle Scholar
  60. 60.
    Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;2(5):357. 454-61.Google Scholar
  61. 61.
    Durnwald CP, Momirova V, Rouse DJ. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2010;23(12):1360–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Lim AC, Schuit E, Bloemenkamp K, et al. 17α-hydroxyprogesteronecaproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol. 2011;118(3):513–20.PubMedCrossRefGoogle Scholar
  63. 63.
    • Senat MV, Porcher R, Winer N. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. Am J Obstet Gynecol. 2013;208(3):194.e1–8. This source confirms the same findings that progesterone is ineffective in prevention of preterm birth even when given as IM injections 17 alpha hydroxyprogesterone acetate and in this study the opposite was found as there was increased incidence of preterm birth <32 weeks. CrossRefGoogle Scholar
  64. 64.
    Serra V, Perales A, Meseguer J. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. BJOG. 2013;120(1):50–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Crowther CA, Han S. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev. 2010;7, CD000110.PubMedGoogle Scholar
  66. 66.
    Hegeman MA, Bekedam DJ, Bloemenkamp KW. Pessaries in multiple pregnancy as a prevention of preterm birth: the ProTwin Trial. BMC Pregnancy Childbirth. 2009;9:44.PubMedCrossRefGoogle Scholar
  67. 67.
    Acharya G, Eschler B, Grønberg M. Noninvasive cerclage for the management of cervical incompetence: a prospective study. Arch Gynecol Obstet. 2006;273(5):283–7.PubMedCrossRefGoogle Scholar
  68. 68.
    Young RC. Myocytes, myometrium, and uterine contractions. Ann N Y Acad Sci. 2007;1101:72–84.PubMedCrossRefGoogle Scholar
  69. 69.
    Bernal AL. The regulation of uterine relaxation. Sem Cell Dev Biol. 2007;18(3):340–7.CrossRefGoogle Scholar
  70. 70.
    Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;4:CD004352.PubMedGoogle Scholar
  71. 71.
    Smith V, Devane D, Begley CM, et al. A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. Eur J Obstet Gynecol Reprod Biol. 2009;142:3–11.PubMedCrossRefGoogle Scholar
  72. 72.
    Yamasmit W, Chaithongwongwatthana S, Tolosa JE. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database Syst Rev. 2012 Sep 12;9, CD004733.Google Scholar
  73. 73.
    Magee L, Sawchuck D, Synnes A, et al. SOGC Clinical practice guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2011;33(5):516–29.PubMedGoogle Scholar
  74. 74.
    Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226.PubMedCrossRefGoogle Scholar
  75. 75.
    Hales KA, Matthews JP, Rayburn WF. Intravenous magnesium sulfate for premature labor: comparison between twin and singleton gestations. Am J Perinatol. 1995;12(1):7–10.PubMedCrossRefGoogle Scholar
  76. 76.
    King JF, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;2:CD001992.PubMedGoogle Scholar
  77. 77.
    Caritis S. Adverse effects of tocolytic therapy. Br J Obstet Gynaecol. 2005;112 Suppl 1:74–8.CrossRefGoogle Scholar
  78. 78.
    Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;204(2):134.e1–134.e20.CrossRefGoogle Scholar
  79. 79.
    Roos C, Spaanderman ME, Schuit E. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. JAMA. 2013;309(1):41–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Derbent A, Simavli S, Gümüş II. Nifedipine for the treatment of preterm labor in twin and singleton pregnancies. Arch Gynecol Obstet. 2011;284(4):821–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Brubaker SG, Gyamfi C. Prediction and prevention of spontaneous preterm birth in twin gestations. Semin Perinatol. 2012;36:190–4.PubMedCrossRefGoogle Scholar
  82. 82.
    King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2002;4:CD000246.PubMedGoogle Scholar
  83. 83.
    Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2003;2:CD001058.PubMedGoogle Scholar
  84. 84.
    MacDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007;1:CD000262.Google Scholar
  85. 85.
    Petousis S, Goutzioulis A, Margioula-Siarkou C. Emergency cervical cerclage after miscarriage of the first fetus in dichorionic twin pregnancies: obstetric and neonatal outcomes of delayed delivery interval. Arch Gynecol Obstet. 2012;286(3):613–7.PubMedCrossRefGoogle Scholar
  86. 86.
    Roman AS, Rebarber A, Pereira L. The efficacy of sonographically indicated cerclage in multiple gestations. J Ultrasound Med. 2005;24(6):763–8. quiz 770-1.PubMedGoogle Scholar
  87. 87.
    Newman RB, Krombach RS, Myers MC. Effect of cerclage on obstetrical outcome in twin gestations with a shortened cervical length. Am J Obstet Gynecol. 2002;186(4):634–40.PubMedCrossRefGoogle Scholar
  88. 88.
    Moragianni VA, Cohen JD, Smith SJ. The role of ultrasound-indicated cerclage in triplets. Ultrasound Obstet Gynecol. 2009;34(1):43–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Obstetrics and GynecologyFetal Medicine Unit Cairo UniversityCairoEgypt
  2. 2.Obstetrics and GynecologyCairo UniversityGizaEgypt
  3. 3.CairoEgypt

Personalised recommendations